ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • Abstract Number: PB1121

    Idarucizumab to Neutralize Dabigatran in a University Hospital: The Relevance of Renal Function

    A. Fattorini1, L. Pozzi2, L. Tomassini1, L. Crippa1, P. Della Valle1, A. D'Angelo1

  • Abstract Number: PB1467

    Idelalisib Selectively Inhibits GPVI-mediated Platelet Activation and Shows Anti-atherothrombotic Activity

    M. Nuñez Barrachina1, I. Izquierdo1, L. Hermida-Nogueira1, L. A. Morán1, A. B. Arroyo2, N. García-Barberá2, R. González-Conejero2, J. Rivera2, C. Martínez2, M. I. Loza3, E. Domínguez3, Á. García1

  • Abstract Number: PB1452

    Identification and Functional Study of a New Germline Variant in Mecom Gene

    N. Papa1, A. Marzollo2, M. Faleschini3, T. Giangregorio3, M. Dall'Arche4, M. Gabelli2,5, C. Tretti2, A. Biffi2, S. Bresolin2, A. Savoia1,3

  • Abstract Number: PB0464

    Identification of a Circulating Lipid Profile Associated with Venous Thromboembolism

    A. Fernandez-Pardo1, J. Oto1, M. Alcoriza2, L. Martos1, E. Plana3, M.J. Solmoirago1, M. Yelo1, F. Cana1, F. Ferrando4, A. Blanquer4, S. Bonanad4, F. España1, P. Medina1, M. Roca5, S. Navarro1

  • Abstract Number: PB/CO04

    Identification of a COVID-19 Subpopulation Responsive to Hydroxychloroquine Using Machine Learning: The IDENTIFY Trial

    C. Lam, S. Mataraso, A. Lynn-Palevsky, A. Green-Saxena, G. Barnes, J. Hoffman, J. Calvert, E. Pellegrini, R. Das

  • Abstract Number: PB0321

    Identification of a Novel “Laminin G” Domain Mutant of Protein S Defective in Binding and Inhibiting FIXa and Unaffected in APC/TFPI Cofactor Activities

    S. Chatterjee, V. Pilli, R. Majumder

  • Abstract Number: PB1506

    Identification of a Novel Molecular Variant in the PTGS1 Gene that Causes a Loss of a Glycan in the Catalytic Domain, Defects in Platelet Thromboxane A2 Synthesis, and Bleeding

    V. Palma-Barqueros1, M. Crescente2, M. Chan2, M.E. de la Morena-Barrio3, J.M. Bastida4, N. Bohdan3, E. Almarza5, S. Suarez-Varela6, I. Casas-Aviles6, J. Padilla3, A. Rodriguez-Alen7, A. Marin-Quilez4, N. Revilla3, V. Vicente3, J. Corral3, M.L. Edin8, D. Zelding8, M.L. Lozano3, T. Warner2, J. Rivera3

  • Abstract Number: PB0194

    Identification of Key Residues in Protein Z Dependent Protease Inhibitor (ZPI) for Efficient Protease Inhibiton

    T. Sengupta1, C.G. Subash2, S. Gupta2

  • Abstract Number: PB1914

    Identification of microRNAs Potentially Involved in Primary Antiphospholipid Syndrome Related Thrombosis

    C. Oliveira Vaz1, M. Vieira Geraldo1, L. Ferreira Alves1, P.E. Nascimento Silva Vasconcelos1, M. Aparecida Cursino1, J. Coelho França Quintanilha1, L. Brito Bastos1, G.L. Tripiquia Vechiatto Mesquita1, B. Cardoso Jacintho1, A.P. Rosa dos Santos1, N. Godoy Torso1, J. Marques de Oliveira2, T. Sereno Cobaxo1, A. Aparecido Geraldo1, J. Bassani Borges3, R.C. Costa de Freitas3, J.M. Annichino-Bizzacchi1, B. Moraes Mazetto1, P. Moriel1, F. Loureiro de Andrade Orsi1

  • Abstract Number: PB0831

    Identification of Novel Genetic Risk Factors in the Conserved Haplotype Region Surrounding the LCT Locus on Chromosome 2q21

    A. Cairo1, E. Pappalardo2, S. Spena2, M. Mancuso1, F. Peyvandi1,2

  • Abstract Number: PB0174

    Identification of Novel Proteins Binding to Coagulation Factor XIII Free B-Subunit

    B. Li, V. Schroeder

  • Abstract Number: PB2278

    Identification of Somatic Mutations Associated with Clonal Hematopoiesis in Unprovoked Venous Thromboembolism

    Á. Fidalgo-Fernández1, M. Hernández-Sánchez2, A. Marín-Quílez2, R. Benito2, S. Santos-Mínguez2, C. Miguel-Gracía2, I. Rodríguez-Iglesias2, S. González-Briones2, M. García-García1, M. Quijada-Álamo2, A. Hortal3, S. Cadenas Menéndez1, J.R. González Porras1, J.M. Hernández-Rivas1,2, J.M. Bastida1

  • Abstract Number: PB0258

    Identification of the Histidine-rich Glycoprotein Domain Responsible for Contact Pathway Inhibition

    T.K. Truong1,2, R.A. Malik1,2, E. Ajewole1, J.C. Fredenburgh1,3, A.R. Stafford1,3, B.A. Leslie1,3, H.M. Madarati1,2, C.A. Kretz1,3, J.I. Weitz1,3

  • Abstract Number: PB1459

    Identification of the Sequence Specificity in C-Src SH3 Required for Binding to Integrin Β3 as a Novel Anti-Thrombotic Target without Compromising Primary Hemostasis

    J. Mao1, Y. Wang1, B. Xiao1, Z. Long1, K. Zhu2, J. Liu2, Z. Ruan1, W. Xi1, C. Luo2, X. Xi1

  • Abstract Number: PB0151

    Identification of Thrombosis Predictors in an ex vivo Shunt Model through Retrospective Analysis

    M.W. Hagen1, H.H.S. Lakshmanan2, M.E. Fallon2, O.J.T. McCarty2, M.T. Hinds2

  • Abstract Number: PB0329

    Identification of Zebrafish Orthologue to Human Factor IX Gene and its Age Dependent Regulation

    N. Iyer, A. Al Qaryoute, M. Kancham, P. Jagadeeswaran

  • Abstract Number: PB0658

    Identifying and Reducing the Cause of Haemolysis in Coagulation Blood Samples due to Sample Transport in a Pneumatic Tube System

    J. Cooper1, F. Broell2, J. van der Hoop2, S. Kitchen1

  • Abstract Number: PB0691

    Identifying DOACs in Mixing Study Samples

    E. Salazar, C. Leveque, J. Chen, B. Castillo

  • Abstract Number: PB1620

    Ikaros/AhR Interaction Favors Expansion of Megakaryocytic Precursors with a High Potential to Produce Proplatelets

    V. Do Sacramento1, L. Mallo1, S. Chan2, C. Gachet1, F. Lanza1, H. de la Salle1, C. Strassel1

  • Abstract Number: PB1835

    Immature Platelet Fraction and Platelet Indices in Acute Coronary Syndrome

    Y. Hernaningsih1, E. Indriastuti1, Y.N. Indrasari1, A. Andrianto2

  • Abstract Number: OC 03.1

    Immune Profiling of Previously Untreated Patients with Severe Haemophilia A by High-throughput Mimotope Variation Analysis

    G. Baselli1, R. Palla2, C. Valsecchi3, K. Palm4, S. Miri5, F. Peyvandi2,3, SIPPET Study Group

  • Abstract Number: PB1356

    Immune Thrombocytopenia Treatment with Fostamatinib, a Spleen Tyrosine Kinase Inhibitor: Reducing the Risk of Thrombosis

    N. Cooper1, I. Altomare2, Y. Kreychman3, V. Markovtsov4, E. Masuda4, S. Tong5, J. Bussel6

  • Abstract Number: PB1025

    Immune Tolerance Induction (ITI) with a Plasma-derived Factor VIII for Patients with Hemophilia A and Inhibitors: A Retrospective Study

    M. Escobar1,2, L. Shaffer3, M. Holguin4, T. McCavit5, N. Amega6, S. Rajan7

  • Abstract Number: PB1001

    Immune Tolerance Induction (ITI) with a Single Factor VIII/von Willebrand Factor Concentrate in Haemophilia A Patients with Inhibitors – Update from the ObsITI Study

    C. Escuriola-Ettingshausen, ObsITI Study Group

  • Abstract Number: PB1086

    Immune Tolerance Induction in Children with Hemophilia A, in Times of Emicizumab: A Real Life Experience

    J. Ardila1, J. Argüello2, G. Martinez2, J. Wilches1, D. Arias2

  • Abstract Number: PB1044

    Immune Tolerance Induction with Octanate® in Patients with Haemophilia A and Inhibitors: An Ongoing Case Series from a Malaysian Centre

    Z. Muda1, S. Zainol2, H. Ibrahim1

  • Abstract Number: PB1047

    Immune Tolerance Induction with Simoctocog Alfa in Patients with Haemophilia A: An Ongoing Multicentre Case Series from the UK

    G.W. Hall1, A. Wilkinson1, M. Mathias2, N. Bhatnagar1, T. Biss3, R.J. Liesner2

  • Abstract Number: PB2000

    Immunization with Recombinant Atherogenic Antigen (AHC) Does Not Enhance Susceptibility to Sepsis

    M. Xia1, V. Endresz2, I. Lantos2, A. Szabo3, X. Lu1

  • Abstract Number: PB0143

    Immunization with Recombinant Atherogenic Antigen (AHC) Does Not Increase Susceptibility to Venous Thrombosis

    M. Xia1, V. Endresz2, I. Lantos2, A. Szabo3, X. Lu1

  • Abstract Number: PB2282

    Immuno-Magnetic Separation (IMS) Allows Efficient and Selective Extraction of Microvesicles Bearing Tissue Factor Activity from Various Liquid Biopsies

    C. Franco1,2, R. Lacroix1,3, L. Vallier1,3, C. Judicone2, T. Bouriche2, S. Laroumagne4, P. Astoul4, F. Dignat-George1,3, P. Poncelet2

  • Abstract Number: PB0027

    Immuno-Radio-Metric TSH in TRH Test of Optimal Substitutive Thyroid Hormones

    E.H. Sidibe1, P.-J. Guillausseau2, A. Warnet3,4

  • Abstract Number: PB2483

    Impact Analysis of Prognostic Stratification for Pulmonary Embolism (iAPP): A Randomized Controlled Trial

    M.P. Donadini1, N. Mumoli2,3, P. Fenu4, F. Pomero5, R. Re6, G. Palmiero7, L. Spadafora5, V. Mazzi3, A. Grittini2, D. Aujesky8, F. Dentali1, W. Ageno1, A. Squizzato9

  • Abstract Number: PB2562

    Impact of 399C/T Polymorphism of Tissue Factor Pathway Inhibitor on Risk of Recurrent Pregnancy Loss in India

    K. Kishor1, A. Sharma2, R. Kumar2, S. Maharana3, R. Ranjan2, M. Mahapatra2, S. Tyagi2, R. Saxena2

  • Abstract Number: PB0975

    Impact of a New Drug in the Real Child´s Life

    G. Sliba, M. Martinez, P. Nally, F. Morales, G. Dolabella, F. Nally

  • Abstract Number: PB1281

    Impact of a Perioperative Venous Thromboembolism Prophylaxis Screening Tool for Pediatric Orthopedic Surgical Patients

    W. MacNevin1, K. Padhye2, V. Price1, R. ElHawary2, B. Branchford3, S. Stevens4, K. Kulkarni5

  • Abstract Number: PB1242

    Impact of a Standardized, Moderate-Intensity Aerobic Exercise Regimen on Hemostasis in Adolescent Hemophilia A Carriers: A Pilot Investigation

    R. Kumar1,2, M. Carcao3,4, A. Gonzales5, J. Lischak5, P. Widener5, J. Stanek5, A. Waller5, B. Kerlin5,6,7, W. Kahr3,8, M. Rand3,8, D. Lillicrap9, A. Dunn5,6

  • Abstract Number: PB0701

    Impact of Anticoagulant and of Time Elapsed Since Blood Collection on Platelet Function Assessed by Multiple Electrode Impedance Aggregometry

    M. Hardy1,2, S. Lessire3, S. Kasikci4, J. Baudar4, M. Guldenpfennig4, J. Douxfils5,6, J.-M. Dogne5, T.P. Lecompte7, B. Chatelain8, H. Jacqmin8, F. Mullier8

  • Abstract Number: PB0812

    Impact of APTT Reagents on Factor VIII Assay in Plasma Spiked with a Pegylated Recombinant FVIII: A French Multicentre Study

    C. Pouplard1,2, F. Grand3, I. Harzallah4, E. Jeanpierre5, D. Lasne6, C. Nougier7, Y. Repesse8, A. Ryman9, A.F. Serre Sapin10, S. Voisin11, C. Ternisien12,13

  • Abstract Number: PB2289

    Impact of Beta-Blockers on the Clinical Diagnosis of Patients with Pulmonary Embolism

    F. Moustafa1,2, B. Desmarie1, N. Breuil1, N. Dublanchet1, D. Teissandier1, J. Schmidt1,2

  • Abstract Number: PB1313

    Impact of Blood Group on the Incidence of Thrombosis in Neonates

    K. Bhatia, S. Solanki, B. Paes, A.K. Chan, M.D. Bhatt

  • Abstract Number: PB0634

    Impact of Centrifugation on Thrombin Generation Analysis Evaluated in Healthy Subjects and Patients Treated with Direct Oral Anticoagulants

    M. Hardy1,2, C. Dellanoce3, J. Douxfils4,5, L. Sarah2, A. Carlo6, S. Testa3, F. Mullier1

  • Abstract Number: PB2324

    Impact of Clostridium Difficile Infections on In-Hospital Outcomes of Venous Thromboembolism (DVT or PE) Hospitalizations

    K. Jhaveri1, D. Ludhwani2, A. Vakiti3, S. Surani4

  • Abstract Number: PB0537

    Impact of Combination of Factor VIII-Deficient Plasma and Activator in One-Stage Clotting Assay on Potency Testing of Factor VIII Products

    A. Suzuki1, N. Suzuki2, T. Kanematsu3, S. Okamoto4, S. Tamura5, T. Kojima5, T. Matsushita2,3

  • Abstract Number: PB2327

    Impact of Competing Risk of Death on the Cumulative Incidence of Venous Thromboembolism in a Nationwide Danish Cohort of Men and Women

    C.A.L. Arnesen1, K. Veres2, N. Skajaa2, E. Horváth-Puhó2, H.T. Sørensen2, J.-B. Hansen1,3, S.K. Brækkan1,3

  • Abstract Number: PB0163

    Impact of DOACs on Hemostasis Diagnostic Tests. Practical Recommendations and Guidance for the Laboratory

    R. Siriez1, J.-M. Dogné1,2, J. Laloy2,3, J. Douxfils1,4

  • Abstract Number: PB1059

    Impact of Extended Half-life Product versus Conventional Factor Product in Children with Hemophilia A – Findings from a Tertiary Care Centre

    M. Saleh1, H. Alzahrani2, T. Owaidah3, A. Aljefri1, D. Mohammed4, B. Safi5, V. Mohammed1

  • Abstract Number: PB0034

    Impact of Gut Microbiota on Late Atherosclerosis and Atherothrombosis: A Study with Germ-Free Mice

    G. Pontarollo1, K. Kiouptsi1, S. Jäckel1,2, M. Kuijpers3, C. Weber4,5, C. Neideck3,4, M. Nagy3, Y. Jansen4, U. Walter1,2, K. Jurk1,6, J. Heemskerk3, E. van der Vorst4,7, Y. Döring4,7,8, C. Reinhardt1,6

  • Abstract Number: PB1287

    Impact of Inherited Thrombophilia on Risk of a First Perinatal Arterial Stroke and Futher Course or Recurrence Rates: A Systematic Review and Meta-Analysis of Observational Studies

    T. Bajorat1, B. Kiesau1, M. Shneyder1, P.M. Kuta1, D. Kowalski1, A. Rocke1, G. Keneth2, R. Junker1, U. Nowak-Göttl1

  • Abstract Number: PB1261

    Impact of Intravenous Iron Therapy in Post-menarchal Adolescents Hospitalized with Acute Heavy Menstrual Bleeding

    H. Han1, A.S. Cohen1, K.A. Staggers2, L. Srivaths1

  • Abstract Number: PB1615

    Impact of Irradiation on the Bone Marrow Matrix and Megakaryopoiesis

    K. Faber1, D. Semeniak1, K.G. Heinze2, H. Schulze1

  • Abstract Number: PB2156

    Impact of Obesity in Pulmonary Embolism among Patients with Solid Malignancies

    K. Quelal1, A. Torres1, C. Torres2, A. Tafur3

  • Abstract Number: OC 01.5

    Impact of Platelet-Selective TGF-β1-Deficiency in Atherogenesis and CD4+ T Effector Responses Using a No-Germline Genetic Engineering Atherosclerosis Mouse Model

    S. Tan1, Y. Sun2, A. Gisterå1, Y. Min1, J. Zhang1, C. Ma2, N. Li1

  • Abstract Number: PB1039

    Impact of Prophylactic Treatment Incorporation in Hemophilia A and B Hospitalization Rates of the State of São Paulo Patients – Brazil – from 2008 to 2018

    A.C. Guersoni1, P. Vilaça2, V. Rocha2, E. Trindade3, O.D.C. Luiz1

  • Abstract Number: PB0091

    Impact of Protease Nexin-1 in Cerebral Ischemia

    L. Venisse, S. Dupont, Y. Boulaftali, B. Ho-Tin-Noe, V. Arocas, M.-C. Bouton

  • Abstract Number: OC 12.3

    Impact of SERPINC1 Mutation on Thrombotic Phenotype in Children with Congenital Antithrombin Deficiency – First Analysis of the International Society on Thrombosis and Hemostasis (ISTH) Pediatric AT Database and Biorepository

    R. Kumar1,2, N. Bakeer3, A. Al Mughairy4,5, J. Dawson6, J. Stanek7, A. Dunn7,8, A. Chan9,10, C. Male11, J. Forman-Kay12,13, S. Williams4,5

  • Abstract Number: PB2322

    Impact of Socioeconomic Status on the Risk of Receiving a Permanent Work-Related Disability Pension After Incident Venous Thromboembolism

    H. Jørgensen1, E. Horváth-Puhó2, K. Laugesen2, S. Braekkan1,3, J.-B. Hansen1,3, H.T. Sørensen2

  • Abstract Number: PB0981

    Impact of Switching to Prophylaxis with Recombinant Factor IX Fc Fusion Protein Concentrate on Patient Reported Outcomes in People with Haemophilia B Using the PROBE Questionnaire

    M. O'Donovan1,2, K. Johnston1,2, E. Singleton1, J. Benson1, K. Ryan1, N. O'Connell1,2

  • Abstract Number: PB1891

    Impact of Ultralarge von Willebrand Factor (VWF) Multimers and Platelets in Cultured Endothelial Cells in Acute Immune-mediated Thrombotic Thrombocytopenic Purpura

    C. Vendramin1, F. Patella2, C. Lupo1, D. Cutler2, M. Scully1,3

  • Abstract Number: PB2544

    Impaired Platelet Contractility in Women with a History of Miscarriage

    S.I. Safiullina1,2, A.D. Peshkova1, N.G. Evtugina1, R.I. Litvinov1,3, J.W. Weisel3

  • Abstract Number: PB2488

    Implementation of a Text-message Intervention to Warfarin Users in a Brazilian Primary Care Setting

    M. Viana Rego Souza e Silva1, M. Luiza de Paiva Rodrigues2, A. Oliveira Baldoni2, B. Gabriela Rocha2, M. Cesar Raposo2, T. Lorenna Souza Sales2, J. Antonio Queiroz de Oliveira3, A.L. Ribeiro3, M. Soriano Marcolino3

  • Abstract Number: PB1217

    Implementation of Prefilled Doses- A Novel Approach to Decrease Medication Time to Administration and Errors In Critically Ill Pediatric Patients of Emergency Department (ED)

    F. Perveen, A. Shah

  • Abstract Number: PB0282

    Implementation of the Management of Anticoagulation in the Periprocedural Period (MAPPP) App into an Electronic Health Record (EHR): A Prospective Cohort Study

    A. Spyropoulos1,2, D. Giannis1, J. Cohen2,3, S. John3, A. Myrka4, D. Inlall1, S. Akgul5, R. Hyman6, J. Wang1,2

  • Abstract Number: PB1687

    Implication of Platelet Adhesiveness in the Risk of Venous Thromboembolic Disease

    D. Jerez1, M. Diaz-Ricart1,2, M. Arús3, S. Torramadé-Moix1, P. Molina1, A. Ramos1, M. Carrasco3, N. Villalta3, V. Martinez3, D. Llobet3, P. Sanchez4, M. Palomo1,2,5, F. Vidal6,7,8, G. Escolar1,9, J.C. Souto3

  • Abstract Number: PB0961

    Implication of Weight Excess in Hemophilic Arthropathy. The Results of a Colombian Reference Center

    J. Lopez-Lopez1, C. Sossa-Melo2, A. Peña-Castellanos3, E.A. Wandurraga2, D. Ney-Salazar4, J. Otero-Wandurraga5

  • Abstract Number: PB0040

    Importance of Arginase-1 in Erythrocytes for Smooth Muscle Cell Calcification and Atherosclerosis

    R. Gogiraju1, L. Renner1, M. Molitor1,2, S. Danckwardt2, T. Münzel1, P. Wenzel1,2, K. Schäfer1

  • Abstract Number: PB1639

    Importance of Platelet Contractility at Different Stages of Thrombus Formation

    M. Kenny1,2, S. Lickert3, V. Vogel3, D. Kenny1,2, I. Schoen1,2

  • Abstract Number: PB0252

    Importance of the Non-Catalytic Heavy Chains of the Homologs Factor XII and HGFA in Protease Function

    A. Shamanaev, I. Ivanov, M.-F. Sun, D. Gailani

  • Abstract Number: PB1764

    Important Role for SHARPIN in Supporting Platelet Linear Ubiquitination and Thrombus Formation

    S.F. Moore1, J.L. Huntchinson1, X. Zhao1, J. Ivaska2, I. Hers1

  • Abstract Number: PB1202

    Important Sex Differences in Patients with Autosomal Inherited Bleeding Disorders

    F. Atiq1, J.L. Saes2, K. Meijer3, M.H. Cnossen4, R.E.G. Schutgens5, B.A.P. Laros-van Gorkom2, M. Peters6, L. Nieuwenhuizen7, K.P.M. van Galen5, J. de Meris8, J.G. van der Bom9,10, F.J.M. van der Meer11, K. Fijnvandraat6,12, I.C. Kruis8, W.L. van Heerde2, J. Eikenboom11,13, S.E.M. Schols2, F.W.G. Leebeek1, WiN and RBIN Study Groups

  • Abstract Number: PB1274

    Improve the Quality of Life in Children with Thrombosis and Need for Oral Anticoagulation: The “Coagulin Project”

    R. Martos Martínez1, M. Yuste Platero1, E. Gonzalez Arias1, L. Bermejo Martínez2, P. Beltrán Álvarez2, A. Pascual Martínez2, D. Cornejo Corrales1, P. Llamas Sillero3

  • Abstract Number: PB0002

    Improved Antithrombotic Activity and Diminished Bleeding Side Effect of a PEGylated αIIbβ3 Antagonist, Disintegrin

    Y.-J. Kuo1, W.-J. Chuang2, T.-F. Huang1,3

  • Abstract Number: PB0480

    Improved Functional and Biochemical Characteristics of Buffy-Coat Platelet Concentrates Stored in Citrate-Free PAS-III Additive Solution for 7 Days

    H. Isola, C. Ravanat, F. Rudwill, A. Pongerard, D. Haas, A. Eckly, C. Gachet, B. Hechler

  • Abstract Number: PB0937

    Improved Prophylaxis Adherence After Switching to Emicizumab: Real-World Data from a Single Center

    T.W. Buckner, O. Rapacchietta, D. Hill, B. Warren, M. Manco-Johnson, C. Ng, G. Moyer, B. Branchford, R. Shearer, J. Smith, D. Thornhill, M. Wang

  • Abstract Number: PB1130

    Improved Sensitivity of Global Hemostasis Assays Using Different Combinations of Phospholipid Reagent and Tissue Factor

    P. Soni, R. Patil, S. Shetty

  • Abstract Number: PB2457

    Improvements in Short- and Long-term Outcomes in Patients with Pulmonary Embolism after Outpatient Pulmonary Rehabilitation

    S. Nopp1, F.A. Klok2, F. Moik1, M. Petrovic3, I. Derka3, C. Ay1, R.H. Zwick3

  • Abstract Number: PB0667

    Improving Comparability of Optical Aggregometry Results from Automated Coagulation Analyzer Systems Compared with a Manual Aggregometer

    F. Prüller1, J. Rabensteiner1, A. Riegler2, H. Mangge1, E. Mahla1, M. Herrmann1, D. von Lewinski1

  • Abstract Number: PB1089

    In the Future, Will ADSCs Become the Target Cells for Hemophilia A Gene Therapy?

    Z.Y. Yan1, J. Li1, Y. Zhu2, Y. Xie1, L. Wang3, X. Wang4, H. He4, Q. Sun4

  • Abstract Number: PB2019

    In Vitro Disruption of Endothelial Barrier Integrity by Heme and by Serum from Patients with Sickle Cell Disease

    V.A.G. Santaterra1, M.M.L. Fiusa1, B.W. Hounkpe1, F. Chenou1, L.N.G. Costa1,2, D. Garcia-Weber3, I.D.F. Domingos4, A.D.S. Araujo5, A.R. Lucena-Araujo4, M.A. Bezerra4, M.N. Santos1, F.F. Costa1, J. Millan3, E.V. De Paula1

  • Abstract Number: PB0031

    In vitro Occlusive Clot Growth and Retraction

    B.J.M. van Rooij1, G. Zavodszky1, A.G. Hoekstra1, D.N. Ku2

  • Abstract Number: PB1716

    In-Depth Platelet Releasate Proteome Profiling: A Novel Source of Biomarkers for Early-Onset Preeclampsia

    P.B. Szklanna1,2, M.E.M. Parsons1,2, K. Wynne3, H. O'Connor4, M. Higgins5,6,7, K. Egan1, F. Ni Ainle1,5,8, P.B. Maguire1,2,9

  • Abstract Number: PB0016

    In-Vivo Biomarkers of Platelet Function in Women with Ischemic Heart Disease: What We Learned from the EVA Study

    L. Stefanini1, G.F. Romiti1, M. Proietti2, S. Bartimoccia3, R. Carnevale3, S. Basili1, V. Raparelli4, EVA Collaborators

  • Abstract Number: PB0264

    In-vivo Evidence for Contact Activation after Implantation of a Left Ventricular Assist Device in Patients with End-stage Heart Failure

    O. Liesdek1, R. Urbanus2, L. de Heer1,3, S. Sebastian4, A. Vink5, K. Fischer2, W. Suyker1, R. Schutgens2

  • Abstract Number: PB0238

    Inactivation of Tissue Factor Pathway Inhibitor through Specific Citrullination by Peptide Arginine Deiminase 4

    R. Koenen1, S. Thomassen1, D. Suylen1, F. Bouwman2, T. Hackeng1

  • Abstract Number: PB2082

    Inappropriate Dosing of Direct Oral Anticoagulants in Older Patients with Non-Valvular Atrial Fibrillation: Impact on Plasma Drug Levels

    A.-L. Comans1, M. Regnier2, B. Bihin2, F. Mullier3, M. de Saint-Hubert1,4, A.-L. Sennesael5

  • Abstract Number: PB2109

    Incidence and Risk Factors for Venous Thromboembolism (VTE) among Lymphoma Patients in a Southeast Asian Population

    V.C.L. Chong1,2, P.S. Chia3, E.S. Yap3,4

  • Abstract Number: PB2362

    Incidence and Risk Factors of Venous Thromboembolism in Patients Undergoing Bariatric Surgery

    V. Baez1, H. Latif1, A.G. Shenoy1, H. Wang2, J.M. Hughes2, T.R. Shope3, K. Fitzpatrick1

  • Abstract Number: PB2330

    Incidence of Chronic Thromboembolic Pulmonary Hypertension: Results from a Longitudinal Prospective Cohort (Osiris Study)

    R. Otero-Candelera1,2, J.L. Lobo-Beristain2,3, R. López-Reyes4, C. Fernández-Capitan5, D. Jimenez-Castro2,6, M. Alfonso-Imizcoz7, A. Ballaz-Quincoces8, A. Nuñez-Ares9, C. Rodriguez-Matute10, J. De Miguel-Diez11, D. Rodriguez-Chiaradia2,12, M. Alcalde-Manero13, F. García-Bragado Dalmau14, L. Hernandez Blasco15, F. Uresandi-Romero16, O. Madridano-Cobos17, A. Muriel-García2,6, M. Monreal-Boch2,18

  • Abstract Number: PB0998

    Incidence of Factor VIII and IX Inhibitors in Hemophilia A and B in China

    X. Dou, X. Song, R. Yang

  • Abstract Number: PB0880

    Incidence of Neutralizing Antibody (Inhibitor) in Previously Untreated Patients (PUPs) with Severe Hemophilia A

    S. Apte, R. Phatale, K. Subramanian, A. Joshi

  • Abstract Number: PB0112

    Incidence of Recurrent Ischemic Stroke in Patients without Atrial Fibrillation: A Real-world Study

    J. Weaver1, L. Wang1, J. Hardin1, J. Foody2, G. Peters2, Z. Yuan1

  • Abstract Number: LB/CO01.3

    Incidence of Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalisation

    M.M. Engelen, T. Vanassche, T. Balthazar, E. Claeys, J. Gunst, M. Jacquemin, S. Janssens, N. Lorent, L. Liesenborghs, K. Peerlinck, G. Pieters, S. Rex, P. Sinonquel, L. Van der Linden, C. Van Laer, R. Vos, J. Wauters, A. Wilmer, P. Verhamme, C. Vandenbriele

  • Abstract Number: PB0867

    Incidence, Presentation and Management of Pseudotumors in Hemophilics: A Systemic Review

    R. Akbar

  • Abstract Number: PB2162

    Incidence, Risk Factors and Clinical Outcome of Venous and Arterial Thromboembolic Events in Patients Treated with Immune-checkpoint Inhibitors: A Single-center Cohort Study

    F. Moik1, W.-S.E. Chan1, S. Wiedemann1, C. Höller2, F. Tuchmann2, M.-B. Aretin3, T. Fuereder4, S. Zöchbauer-Müller4, M. Preusser4, I. Pabinger1, C. Ay1

  • Abstract Number: PB2298

    Incidental Pulmonary Embolism in an Internal Medicine Department

    I. Naceur, Z. Zarrouk, F. Said, T. Ben Salem, H. Baccouche, N. Ben Romdhane, M. Khanfir, I. Ben Ghorbel, M. Lamloum, M.H. Houman

  • Abstract Number: PB1090

    Increase in the Treatment Efficacy of Genome Editing for Hemophilia B by Codon-Optimization of SaCas9 in Mice

    T. Hiramoto1, M. Hayakawa1, N. Kamoshita1, Y. Kashiwakura1, H. Nishimasu2, N. Osamu2, T. Ohmori1

  • Abstract Number: PB1899

    Increased Baseline Platelet Activation and Decreased Platelet Reactivity in Patients with the Antiphospholipid Syndrome

    L. Hell, L.-M. Mauracher, J. Roiß, M. Krall, J. Gebhart, C. Ay, I. Pabinger

  • Abstract Number: PB2110

    Increased Coagulation Potential in Patients with Polycythemia Vera and Essential Thrombocythemia with Thrombotic History

    N. Korsakova, O. Golovina, O. Matvienko, N. Silina, E. Efremova, M. Fominykh, V. Shuvaev, S. Voloshin, L. Papayan

  • Abstract Number: PB/CO15

    Increased Doses of Low-molecular-weight Heparin in Hospitalized Patients with Covid-19

    I. Martinelli1, A. Ciavarella1, M. Abbattista1, S. Aliberti2,3, V. De Zan3, C. Folli4, M. Panigada5, A. Gori3,6, A. Artoni1, A.M. Ierardi7, G. Carrafiello7, V. Monzani4, G. Grasselli3,5, F. Blasi2,3, F. Peyvandi1,3

  • Abstract Number: PB2226

    Increased Levels of Procoagulant Factors and the Risk of Venous Thromboembolism

    L. Spiezia, E. Vedovetto, M. Marobin, E. Borella, G. Turatti, P. Simioni

  • Abstract Number: PB0128

    Increased Levels of von Willebrand Factor Associated with Acute Inflammation Contribute to Enhanced Venous Thrombosis

    S.J. Choi1, L. Swystun1, C. Hindmarch2, C. Dwyer1, A. Michels1, W. Hopman3, D. Lillicrap1

  • Abstract Number: PB0830

    Increased Plasmin Generation in People with Severe Haemophilia

    A.M. Rehill1,2, S. McCluskey1,2, M. Lavin1,2,3, J.S. O'Donnell1,2,3, R.J.S. Preston1,2,4

  • Abstract Number: PB2118

    Increased Potential of Neutrophil Activation and Neutrophil Extracellular Trap Formation in Patients with Lung Cancer

    L.-M. Mauracher1, M. Krall1, F. Moik1, L. Hell1, J. Roiß1, T.M. Hofbauer2, C. Brostjan3, C. Ay1, I. Pabinger1

  • Abstract Number: PB1563

    Increased von Willebrand Factor Levels in Polycythemia Vera and Phenotypic Differences with Essential Thrombocythemia

    M. Sacco1, S. Lancellotti2, G. Petrucci3, P. Ranalli4, A. Dragani4, E. De Candia5, D. Halem6, B. Rocca7, R. De Cristofaro8

  • Abstract Number: PB1578

    Increasing Levels of von Willebrand Factor (VWF) and Factor VIII (FVIII:C) with Age in Patients Affected by von Willebrand Disease (VWD)

    E. Biguzzi1,2, S.M. Siboni3, S. Le Cessie2, L. Baronciani3, F.R. Rosendaal2, A. van Hylckama Vlieg2, F. Peyvandi4,5

  • Abstract Number: PB0272

    Indiscriminate Coagulation Testing for Bleeding Risk Assessment Prior to Orthopedic Surgery. Is it a Rational Approach?

    M. Ali1, M. Harani2

  • Abstract Number: OC 14.4

    Induction of Innate Immune Memory in Macrophages Profoundly Enhances their Procoagulant and Antifibrinolytic Activity

    S. McCluskey1,2, A. Rehill1,2, R. Preston1,2,3

  • Abstract Number: PB1521

    Inertial Forces Generated by a Vortex System Promote Cleavage of von Willebrand Factor

    K. Ashworth1,2, M. Bortot2, A. Sharifi3, F. Walker2, K. Neeves4, D. Bark2,3, J. DiPaola1

  • Abstract Number: PB2405

    Inferior Vena Cava Filter (IVCF) Utilization: Quality Assurance at a Quaternary Care Medical Center

    J. Choe, R. Liang, A. Weinberg, V. Tapson

  • Abstract Number: PB1249

    Inflammation Associated Cell-Free microRNA Levels in Cerebrospinal Fluid of Premature Infants Upon Intraventricular Hemorrhage

    Z. Fejes1, J. Erdei2, J. Takai1, V. Jeney2, A. Nagy3, A. Bácsi4, L. Bognár5, L. Novák5, J. Kappelmayer1, B. Nagy Jr.1

  • Abstract Number: PB0844

    Inflammation in Hemophilia Is Marked by Up-regulation of LPS-binding Protein

    L.M. Knowles, H. Eichler, J. Pilch

  • Abstract Number: PB0515

    Influence of Anticoagulants on the Biomechanical Phenotype of Platelets

    L. Sachs1, L. Lenkeit1, J. Wesche1, A. Greinacher1, O. Otto2, R. Palankar1

  • Abstract Number: PB0446

    Influence of Antiphospholipid Antibodies on Arterial Thrombosis in Myeloproliferative Neoplasia Patients: One Centre Experience

    R. Gerbutavičius1, R. Dambrauskienė1, M. Rudžianskienė1, R. Paukštaitienė2, D. Remeikienė1, A. Vitkauskienė3, E. Skrodenienė3, E. Juozaitytė1

  • Abstract Number: PB1761

    Influence of Bile Acids on Hemostasis and Arterial Thrombosis

    F. Reusswig1, L. Wienands2, M. Reich3, V. Keitel-Anselmino3, M. Elvers2

  • Abstract Number: PB2311

    Influence of Body Mass Index on Outcomes in Patients with Venous Thromboembolism: Insights from GARFIELD-VTE

    J.I. Weitz1,2, W. Ageno3, A.E. Farjat4, A.G.G. Turpie1, S. Haas5, S. Goto6, S.Z. Goldhaber7, P. Angchaisuksiri8, H. Gibbs9, P. MacCallum4,10, M. Carrier11, J. Dalsgaard Nielsen12, G. Kayani4, S. Schellong13, H. Bounameaux14, L.G. Mantovani15,16, P. Prandoni17, A.K. Kakkar4,18, on Behalf of the GARFIELD-VTE Investigators

  • Abstract Number: PB0633

    Influence of DOAC Remove on Coagulation Assays During Thrombophilia Testing in Patients Treated with Rivaroxaban or Dabigatran

    M. Kovac1, D. Basaric2, B. Tomic3, D. Backovic4, S. Lalic Cosic4

  • Abstract Number: PB1840

    Influence of HOCl-modified Myeloperoxidase on Platelet and Neutrophil Activity

    I. Gorudko1, D. Grigorieva1, E. Shamova1, A. Kohan1, O. Panasenko2, A. Sokolov2,3

  • Abstract Number: PB1108

    Influence of N-linked Glycosylation in the A and C Domains on the Immunogenicity of Factor VIII

    A. Vander Kooi1, A. Chen1, J. Joo1, X. Cai1, C.-Y. Chen1, C. Li1, L. Li2, W. Xiao3, B.A. Konkle4, C.H. Miao1

  • Abstract Number: PB1879

    Influence of Personality and Life Conditions on Depression, Anxiety and Cognitive Performance in 104 Patients Having Survived Acute Autoimmune Thrombotic Thrombocytopenic Purpura (iTTP)

    T. Falter1, S. Boeschen1, M. Beutel2, K. Lackner1, B. Lämmle3,4,5, I. Scharrer3

  • Abstract Number: PB0584

    Influence of Phospholipids on the Measurement of Extended Half-Life Factor VIII Activity in One-Stage Clotting Assay

    Y. Fujimori1, S. Madoiwa2,3, S. Shinohara4, O. Kumano4, N. Arai4, A. Igari3, M. Wakui3, M. Murata3

  • Abstract Number: PB0367

    Influence of Specific Therapy on Microparticle-Associated Thrombin Generation in Patients with Primary Myelofibrosis

    O. Matvienko, N. Silina, N. Korsakova, O. Golovina, L. Papayan, E. Efremova, M. Fominyh, V. Shuvaev, S. Voloshin

  • Abstract Number: PB2151

    Influence of Tumor Site on Clinical Outcomes in Cancer Patients with Venous Thromboembolism. Insights from the Prospective PREDICARE Cohort Study

    P. Girard1,2, S. Laporte2,3,4, C. Chapelle4,5, A. Lamblin6, G. Meyer2,7

  • Abstract Number: PB0690

    Inherited Coagulopathies Study by Massive Sequencing (NGS) Experience of a Diagnostic Portuguese Center

    P. Martinho1, C. Silva Pinto1, C. Oliveira2, M.F. Rodrigues2, R. Salvado3, M. Carvalho4, M. Calheiros5, G. Caetano6, L.F. Araújo1, J. Azevedo1, P. Kjollerstrom7, M. Costa8, T. Fidalgo1, M.L. Ribeiro1

  • Abstract Number: PB2236

    Inherited Deficiency of Antithrombin, Protein C or Protein S Is Associated with an Increased Risk of Cancer at a Younger Age

    D. Tormene1, S. Gavasso2, G. Turatti2, C. Simion2, M. Marobin2, E. Campello2, P. Simioni2

  • Abstract Number: PB1212

    Inherited Factor VII Deficiency Associated with Thrombo-hemorrhagic Phenotype: A Case Report

    A. Stryckova, M. Dobrotova, L. Lisa, J. Sokol, L. Stanciakova, T. Simurda, L. Vadelova, M. Brunclikova, J. Stasko

  • Abstract Number: PB1197

    Inherited Factor VII Deficiency in Women: Low Rate of Bleeding in Non-severe Disease

    F. Chuliber1, M. Martinuzzo1,2, V. Privitera3, M. Lopez1, E. Viñuales3, L. Barrera2,3, D. Mezzarobba3, M.E. Fotti Berdasco3,4, M. Villagra Iturre3, M. Trulls1,4, D. Penchasky3, J. Arbelbide1

  • Abstract Number: PB1494

    Inherited Platelet Disorders: Identification of Novel Disease Causing Variants Using Next Generation Sequencing

    D. Boeckelmann, F. Sobotta, S. Fels, H. Glonnegger, F. Loewecke, A. Lenz, B. Zieger

  • Abstract Number: PB1174

    Inherited Rare Bleeding Disorders in Non-Consanguinity

    A. Chuansumrit1, W. Sasanakul1, S. Parapakpenjune2, R. Natesirinilkul3, P. Komwilaisak4, N. Sirachainan for the RBD Study Group.1

  • Abstract Number: PB1450

    Inherited Thrombocytopenia Associated with Haematological Malignancies

    M. Faleschini1, N. Papa2, T. Giangregorio1, F. Pozzani3, A. Pecci4, V. Bozzi4, S. Barozzi4, P. Noris4, C. Marconi5, M. Seri5, F. Giona6, M. Santopietro6, D. De Benedictis6, A. Savoia1,2

  • Abstract Number: PB1425

    Inhibition of 12-LOX with VLX-1005 Has Clinical Utility for Prevention and Intervention of HIT

    R. Adili, V. Putzbach, M. Holinstat

  • Abstract Number: PB1559

    Inhibition of ADAMTS13 Rescues Acquired von Willebrand Syndrome in a Preclinical Mechanical Circulatory Support Animal Model

    S. Deconinck1, S. Jacobs2, C. Nix3, E. Bennek-Schöpping3, C. Vandenbriele4, A.-S. Schelpe1, E. Roose1, I. Pareyn1, B. Meyns2, C. Tersteeg1, S.F. De Meyer1, K. Vanhoorelbeke1

  • Abstract Number: PB0407

    Inhibition of Factor Xa by Specific Reversible Inhibitors Is Selective for Factor Xa Generated by Factor IXa

    C. Kluft1, N. Klip1, S. Talens1, S. Karamzin2, F. Ataullakhanov3

  • Abstract Number: PB1460

    Inhibition of Platelet Adhesion, Thrombus Formation and Fibrin Formation by a Potent αIIbβ3 Integrin Inhibitor

    D.L. van den Kerkhof, M. Nagy, J.W.M. Heemskerk, T.M. Hackeng, I. Dijkgraaf

  • Abstract Number: PB0398

    Inhibition of Protein Disulfide Isomerase (PDI) with PACMA-31 Amplifies LPS-Induced Expression of Tissue Factor (TF) in Monocytes

    L. Beckmann1, M. Voigtländer1, B. Sievers1, A. Schulenkorf1, C. Bokemeyer1, W. Ruf2,3, C.C. Rolling1,4, F. Langer1

  • Abstract Number: PB0153

    Inhibitor against Congenital Coagulation Factor XIII Deficiency: A Case Report

    M. Karimi1, A. Shahsavani1,2, A. Bazrafshan1, M. Bordbar1, O. Zekavat1, H. Tavoosi3, Z. Safarzadeh2, A. Bahmanimehr2, N. Bolandparvaz3

  • Abstract Number: PB1192

    Inhibitor Development in a Patient with Severe Congenital Factor V Deficiency

    N. Pardy1,2, P. Moorehead1,3

  • Abstract Number: PB1013

    Inhibitor Development in Hemophilia A – Refining the Risk Assessment

    A. Duraes

  • Abstract Number: PB1575

    Inhibitor Development in Patients with Type 3 von Willebrand Disease, a Comprehensive Study on a Large Number of Iranian Patients

    G.R. Bahoush1,2, S. Tabibian2,3, M.R. Baghaipour2, F. Ala2, M. Jazebi2, A. Dorgalaleh2,3, R. Hantooshzadeh4, N. Baghaipour5

  • Abstract Number: PB1083

    Inhibitor Epidemiology among People Living with Haemophilia A in South West Nigeria

    A. Bolarinwa, A. Olatinwo, L. Adiat, T. Adeyemo

  • Abstract Number: PB1079

    Inhibitor Formation and Immune Tolerance Induction with Fc-fusion-Protein Recombinant Factor IX in Severe Hemophilia B

    A. Amid1, H. Perkins1, A. Bonnefoy2, J. Gauthier2, M. Carcao3, G.E. Rivard2, R. Klaassen1

  • Abstract Number: PB0325

    Inhibitor Risks Estimation Associated with F9 Genotype Types in Patients with Severe Haemophilia B: Argentine vs EAHAD Database

    P. Radic1, B. Ziegler1, V. Marchione1, K. Waisman1, M.M. Abelleyro1, M. Williams2, D. Neme3, C.D. De Brasi1,4, L. Rossetti1

  • Abstract Number: PB0913

    Inhibitors in Hemophilia: Treatment Challenges in Afghanestan

    S.H. Mousavi1,2, S.A. Mesbah-Namin3, M. Jazebi4, A. Dorgalaeh5, S. Zeinali6,7

  • Abstract Number: PB1887

    Inhibitory Anti Adamts13 Antibodies with a New Rapid Fully Automated Clia Assay

    B. Montaruli1, C. Novelli2, L. Solfietti3, A. Valpreda4, M. Bazzan3, I.L. Beverina2, D. Roccatello3, D. Cosseddu5

  • Abstract Number: PB1993

    Inhibitory Effect of Heparin and Modified Heparin on Neutrophil Migration

    J. Hogwood1, Y. Qiao2, R. Amison2, S. Pitchford2, B. Mulloy2, E. Gray1,2

  • Abstract Number: PB1416

    Insights into Autoimmune Heparin-Induced Thrombocytopenia

    N. Krause, J. Eekels, A. Greinacher

  • Abstract Number: PB0684

    Institutional Review of Reflex Factor Coagulation Testing in Patients with an Unexplained Prolonged aPTT

    E.M. Mansory1, F. Bahodi2, C.W. Phua1

  • Abstract Number: PB0525

    Inter-Centre and Inter-Observer Agreement of Determination of DOACs in Urine Samples of Patients by Means of DOAC Dipstick Test

    J. Harenberg1,2, R. Bauersachs3, J. Beyer Westendorf4,5, M. Crowther6, J. Douxfils7,8, I. Elalamy9,10, S. Hetjens11, P. Verhamme12, C. Weiss11

  • Abstract Number: PB0386

    Inter-Laboratory Variability of the Standardized ETP-Based APC Resistance Assay

    L. Morimont1,2, V. Maloteau2, P. Devel2, J.-M. Dogné2, C. Bouvy1, J. Douxfils1,2

  • Abstract Number: PB1646

    Interaction between Platelets and Streptococcus pneumoniae

    A.F. Aschenbrenner1, S. Handtke1, T.P. Kohler2, S. Hammerschmidt2, A. Greinacher1

  • Abstract Number: PB1415

    Interaction of Unfractionated Heparin and Sulodexide with Functional Anti-Heparin Platelet Factor 4 Antibodies as Investigated in Platelet Aggregation Assays

    A. Farooqui1, D. Hoppensteadt1, O. Iqbal1, C. Bacher1, M. Lewis1, J. Walenga1, A. Kouta1, W. Jeske1, B. Lewis2, J. Fareed1

  • Abstract Number: PB0494

    Interest of Improved Z-Score Bivariate Analysis: Application to a ECAT DDimer Survey

    F. Sobas1, P. Tsiamyrtzis2, C. Nougier1, E. Jousselme1, M.O. Geay Baillat3, M. Beghin4, P. Meijer5

  • Abstract Number: PB0695

    Interference of C – Reactive Protein Level in Activated Partial Thromboplastin Time

    M. Farana Matos, C. Finazzo, E. Taniguchi

  • Abstract Number: PB1760

    Interplay between the Tyrosine Kinases Chk, Csk and Phosphatase CD148 Is Critical for Regulating Platelets in Mice

    Z. Nagy1,2, J. Mori1, V.-S. Ivanova1, A. Mazharian1,3, Y.A. Senis1,3

  • Abstract Number: PB0014

    Interventions Needed in Antithrombotic Therapy in a Real Life Hospitalized Population; Evaluation of Interventions Initiated by a Multidisciplinary Antithrombotic Team Regarding Antithrombotic Agent Combinations in In-Patient Care

    M. van der Veer1, J. Schroeder-Tanka2, S. van Wissen3, N. Khorsand1

  • Abstract Number: PB1407

    Intra-individual Residual Platelet Reactivity upon Antiplatelet Therapy in the Perioperative Period Significantly Differs over Time – What Is the Ideal Moment to Monitor Efficacy of Antiplatelet Therapy in Vascular Patients?

    N.C. Roozendaal1, A.R.T. Brand1, R.T. Urbanus2, G.J. De Borst1, S. Korporaal3

  • Abstract Number: PB2087

    Intracardiac Levels of Soluble P Selectin Is Associated with Ischemic Stroke Risk in Patients with Atrial Fibrillation

    F. Sarkady1, O. Hajas2, A. Kiss2, E. Nagy-Baló2, K.B. Kovács3, Z. Csanádi2, L. Csiba3, Z. Bagoly1,4

  • Abstract Number: PB0850

    Intracellular Visualization of FVIII Protein in Selected Knockouts in the Conventional and Alternative Secretion Pathways

    H. Singer, S. Hazzouri, M. Rath, J. Oldenburg, O. El-Maarri

  • Abstract Number: PB2116

    Intracranial Hemorrhage with Direct Oral Anticoagulants in Patients with Brain Metastases

    A. Leader1,2, E.N. Hamulyák3, B.J. Carney4, M. Avrahami2, J.J. Knip3, S. Rozenblatt5, L.F.M. Beenen6, S. Yust-Katz2,7, M. Coppens3, P. Raanani1,2, S. Middeldorp3, H.R. Büller3, J.I. Zwicker4, G. Spectre1,2

  • Abstract Number: PB0026

    Intravenous Lipid-Based Encapsulated Paclitaxel Nanoparticles Administration Enhances 5-Aminolevulinic Acid- Mediated B- Mode Ultrasound- Guided Focused- Electrohydraulic Shock Wave Sonodynamic Therapy of Intermediated Stage Atherosclerosis

    H. Mehrad1, H. Ahmadi Nobari2

  • Abstract Number: PB1139

    Intravenous Synthetic Platelet Nanotechnology for the Treatment of Bleeding Complications

    A. Sen Gupta

  • Abstract Number: PB1531

    Investigating Pathomolecular Mechanisms of Type 2A VWD Variants Located in D1 and A Domains of the VWF

    H. Yadegari, A. Biswas, J. Oldenburg

  • Abstract Number: PB1544

    Investigating the Relationship between VWF Multimeric Pattern and VWF: RCo Activity through Population PK Modeling in Patients with Severe VWD Treated with Recombinant VWF

    A. Bauer1, G. Smania2, S. Friberg-Hietala2, B. Ploder1, B. Mellgård3, M. Wolfsegger1

  • Abstract Number: PB1102

    Investigating the Stability of Lentiviral Vector Targeted Liver Cells during Post-Natal Growth for in Vivo Gene Therapy of Hemophilia

    M. Milani1, F. Starinieri1,2, C. Canepari1,2, T. Liu3, F. Moalli4, G. Ambrosi2,4, T. Plati1, M. Biffi1, C. Covino4, T. Nichols5, M. Iannacone4, R. Peters3, L. Naldini1,2, A. Cantore1,2

  • Abstract Number: PB2036

    Investigation of a Significant Factor to Improve an Establishment of Endothelial Colony Forming Cell

    S. Okamoto1, N. Suzuki2, T. Kanematsu3, A. Suzuki4, K. Odaira5, M. Tokoro5, Y. Hayakawa5, S. Tamura5, F. Hayakawa5, H. Kiyoi1, T. Kojima5, T. Matsushita6

  • Abstract Number: PB2522

    Investigation of Risk Factors of Deep Vein Thrombosis during Pregnancy Using a CFD Model

    Q. Jimoh-Taiwo, R. Haffejee, M. Ngoepe

  • Abstract Number: PB0308

    Investigation of Several Four Factor PCCs to Restore Thrombin Generation Following Anticoagulation with Rivaroxaban: Ex vivo Study

    K. Deventer, F. Rayadoost, H. Sieben, O. Grottke

  • Abstract Number: PB0300

    Investigation of the Coagulation Potential of PAS-E Resuspended Platelets

    A. Lotens1, S. Horman2, A. Rapaille1, S. Eeckhoudt3

  • Abstract Number: PB2446

    Investigation of the Optimal Dose of aPCC in Reversing the Effect of Factor Xa Inhibitors Rivaroxaban and Apixaban- an in vitro Study

    N.H. Schultz1,2,3, J. Fareed4, P.A. Holme1,2,5

  • Abstract Number: PB1376

    Investigations of the Impact of Sialidase-mediated Changes on the Life Span of Human Platelets Using a Humanized in vivo Mouse Model

    L. Pelzl1, I. Marini1, J. Zlamal1, K. Althaus1,2, T. Bakchoul1,2

  • Abstract Number: PB1040

    Is intracranial haemorrhage in haemophilia patients still a present risk in the third millennium? The final results of the EMO.REC Registry: a 10-year Italian study on intracranial haemorrhage in haemophilia patients

    E. Zanon1, S. Pasca2, F. Demartis3, A. Tagliaferri4, C. Santoro5, I. Cantori6, A.C. Molinari7, C. Biasioli8, A. Coppola4, G. Castaman3, S. Linari3, M. Luciani9, G. Sottilotta10, I. Ricca11, B. Pollio11, A. Borchiellini12, E. Santagostino13, P. Simioni14

  • Abstract Number: PB2355

    Is Low Molecular Weight Heparin-Calibrated Chromogenic Anti-Xa Assay Suitable for Assessing Anticoagulant Effect of Apixaban in Adolescents?

    I. Ćelap1, S. Margetić1, R. Mihić1, J. Obuljen2, I. Linarić2, J. Leniček Krleža2

  • Abstract Number: PB2233

    Is May-Thurner Syndrome a Forgotten Cause of Deep Vein Thrombosis?

    S. Lopes, R. Pombal, L. Vieira, D. Ferreira, H. Cruz Gomes, M. Figueiredo

  • Abstract Number: PB1824

    Is Platelet Hyper-Reactivity a Modifiable Risk Factor in Inflammatory Arthritis?

    D. Kenny1, E. Dunne1, K. Leamy2, G. McCarthy2

  • Abstract Number: PB1084

    Is Radiosynovectomy a Tool in Advanced Hemophilic Arthropathy?

    G. Ocampos1, F. Farias1, E. Okazaki2, P. Villaca2, M. Rezende1

  • Abstract Number: PB2373

    Is the Caprini Score a Reliable Tool to Predict the Risk of Venous Thrombosis in Orthopedic Patients?

    R. Zambelli1,2, B. Nemeth3, C. Touw3, F. Rosendaal3, S. Rezende1, S. Cannegieter3

  • Abstract Number: PB1881

    Is Therapeutic Plasma Exchange (TPE) Still Necessary for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)?

    P. Knoebl1, J. Thaler1, M. Krstic2, W. Grandits2, W. Sperr1

  • Abstract Number: PB2265

    Is There a Predictive Value of High Mean Platelet Volume in Early Diagnosis of Venous Thromboembolism in the Emergency Department?

    A. Braester1,2, G. Stemer3, S. Khouri4, M. Barhoum2,4, B. Raviv5,6

  • Abstract Number: PB1280

    Ischemic Strokes in Children

    K. Papayan, M. Rakova, E. Dzhanklich, A. Gurina, E. Kvapinskaya, A. Morozova, A. Shulat'eva, N. Nemstsveridze

  • Abstract Number: PB1168

    Isolated Factor VII Deficiency

    A. Amira, D. Nourhan, B. Hacene, O. Hanifa

  • Abstract Number: PB1246

    Isolated Thrombocytopenia in Children Is Not Always an Immune-Associated Disorder

    A. Adramerina1, A. Teli1, A. Moraitis1, S. Theodoridou2, M. Economou1

  • Abstract Number: PB0615

    ISTH SSC Plasma Standard Lot #5 – Results in a UK National External Quality Assessment Scheme for Blood Coagulation (NEQAS BC) Exercise

    I. Jennings, S. Kitchen, D. Kitchen, S. Munroe-Peart, A. Lowe, L. Brown, I. Walker

  • Abstract Number: PB1906

    IVF Outcomes in Women with Antiphospholipid Antibodies Circulation

    J. Khizroeva, A. Makatsariya, V. Bitsadze, M. Arslanbekova, K. Sultangadzhieva

Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2021 John Wiley & Sons, Inc. All Rights Reserved.
Wiley
This site uses cookies: Find out more.